{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:15:39Z","timestamp":1774289739439,"version":"3.50.1"},"reference-count":46,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective.\u2014To evaluate the usefulness and feasibility of measuring plasma von Willebrand factor (vWF)-cleaving metalloprotease activity (ADAMTS 13) in the differential diagnosis of thrombotic thrombocytopenic purpura (TTP), the hemolytic uremic syndrome, and other thrombotic microangiopathies.<\/jats:p>\n                  <jats:p>Data Sources.\u2014Articles published in the medical literature.<\/jats:p>\n                  <jats:p>Data Extraction and Synthesis.\u2014In TTP, a multimeric form of vWF that is larger than that ordinarily found in the plasma may cause systemic platelet aggregation under the high-shear conditions of the microcirculation. ADAMTS 13 is a divalent cation-activated, vWF-cleaving metalloprotease that converts unusually large vWF multimers derived from endothelial cells into smaller vWF forms in normal plasma. ADAMTS 13 is severely reduced or absent in most patients with TTP. The vWF-cleaving metalloprotease is present in fresh-frozen plasma, cryoprecipitate-depleted plasma (cryosupernatant), and in plasma that has been treated with solvent and detergent. The enzyme is defective in children with chronic relapsing TTP. Infusion of any of the plasma products that contain the vWF-cleaving metalloprotease stops or prevents (for about 3 weeks) TTP episodes in these patients. An immunoglobulin (Ig) G autoantibody to the vWF-cleaving metalloprotease is found transiently in many adult patients with acquired acute idiopathic, recurrent, and ticlopidine\/clopidogrel-associated TTP. Patients with acquired TTP require plasma exchange, that is, both infusion of a plasma product containing vWF-cleaving metalloprotease and removal of autoantibody and\/or unusually large vWF multimers by plasmapheresis. The pathophysiology of platelet aggregation in bone marrow transplantation\/chemotherapy-associated thrombotic microangiopathy, as well as in hemolytic uremic syndrome, is not established. In neither condition is there a severe decrease in plasma vWF-cleaving metalloprotease activity, as there is in TTP.<\/jats:p>\n                  <jats:p>Conclusions.\u2014The presently available lengthy and complicated procedure for estimation of plasma vWF-cleaving metalloprotease activity is not yet practical for rapid diagnostic use. This test has supplanted the equally lengthy and difficult, less specific analysis of plasma vWF multimeric pattern. If the clinical distinction between TTP and hemolytic uremic syndrome is uncertain, it is appropriate to acquire (before therapy) a citrate-plasma sample for the ultimate determination of vWF-cleaving metalloprotease activity.<\/jats:p>","DOI":"10.5858\/2002-126-1430-ttpath","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T12:17:48Z","timestamp":1611922668000},"page":"1430-1433","source":"Crossref","is-referenced-by-count":25,"title":["Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome"],"prefix":"10.5858","volume":"126","author":[{"given":"Joel L.","family":"Moake","sequence":"first","affiliation":[{"name":"From Baylor College of Medicine and Rice University, Houston, Tex"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"2021012917163511400_i1543-2165-126-11-1430-b1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b2","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion.","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma.","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress induced platelet aggregation.","volume":"78","author":"Moake","year":"1986","journal-title":"J Clin Invest"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor cleaving protease.","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of von Willebrand factor cleaving protease and its identification as a new member of the metalloproteinase family.","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b8","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor cleaving protease (ADAMTS 13), a metalloprotease involved in thrombotic thrombocytopenic purpura.","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b9","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b10","first-page":"2244","article-title":"Deficient activity of von Willebrand's factor cleaving protease in patients with disseminated malignancies.","volume":"59","author":"Oleksowicz","year":"1999","journal-title":"Cancer Res"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b11","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b13","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614408","article-title":"Recovery and half-life of von Willebrand factor cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.","volume":"81","author":"Furlan","year":"1999","journal-title":"Thromb Haemost"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel.","volume":"342","author":"Bennett","year":"2000","journal-title":"New Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies of von Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura.","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/0003-4819-132-10-200005160-00005","article-title":"Antibody inhibitors to von Willebrand factor metalloproteinase and increased von Willebrand factor-platelet binding in ticlopidine-associated thrombotic thrombocytopenic purpura.","volume":"132","author":"Tsai","year":"2000","journal-title":"Ann Int Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b18","first-page":"1635","article-title":"Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells.","volume":"256","author":"Frangos","year":"1989","journal-title":"Am J Physiol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1084\/jem.193.12.1341","article-title":"Control of von Willebrand factor multimer size by thrombospondin-1.","volume":"193","author":"Xie","year":"2001","journal-title":"J Exp Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.2830200110","article-title":"Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine.","volume":"20","author":"Moake","year":"1985","journal-title":"Am J Hematol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood.V84.2.490.490","article-title":"Solvent\/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura.","volume":"84","author":"Moake","year":"1994","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(85)90180-X","article-title":"Immunochemistry of vascular lesions in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen.","volume":"38","author":"Asada","year":"1985","journal-title":"Thromb Res"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P","article-title":"Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.","volume":"57","author":"Chow","year":"1998","journal-title":"Am J Hematol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b25","first-page":"9","article-title":"Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.","volume":"87","author":"Moake","year":"1989","journal-title":"Am J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-8652(200011)65:3<251::AID-AJH13>3.0.CO;2-2","article-title":"High titers of inhibitors of von Willebrand factor cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura.","volume":"65","author":"Tsai","year":"2000","journal-title":"Am J Hematol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/00006450-200105000-00008","article-title":"von Willebrand factor and von Willebrand factor cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.","volume":"49","author":"Tsai","year":"2001","journal-title":"Pediatr Res"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases.","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Int Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajh.2830340303","article-title":"Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura.","volume":"34","author":"Byrnes","year":"1990","journal-title":"Am J Hematol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V65.5.1232.1232","article-title":"Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.","volume":"65","author":"Moake","year":"1985","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b31","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases.","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b32","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1055\/s-0037-1614778","article-title":"Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?","volume":"82","author":"Mannucci","year":"1999","journal-title":"Thromb Haemost"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(94)91227-0","article-title":"Haemolytic-uremic syndrome: basic science.","volume":"343","author":"Moake","year":"1994","journal-title":"Lancet"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0002-9440(10)65380-1","article-title":"Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.","volume":"154","author":"Taylor","year":"1999","journal-title":"Am J Pathol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome.","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b37","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated thrombotic thrombocytopenic purpura.","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V93.4.1264.404k16_1264_1270","article-title":"Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura.","volume":"93","author":"Dang","year":"1999","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b39","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(05)64019-6","article-title":"Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura.","volume":"350","author":"Tarantolo","year":"1997","journal-title":"Lancet"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0308-2261(18)30024-9","article-title":"Thrombotic thrombocytopenic purpura and the hemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.","volume":"15","author":"Byrnes","year":"1986","journal-title":"Clin Haematol"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0889-8588(05)70348-8","article-title":"Thrombotic microangiopathies associated with drugs and bone marrow transplantation.","volume":"10","author":"Moake","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura hemolytic uremic syndrome: clinical experience in 108 patients.","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura hemolytic uremic syndrome.","volume":"96","author":"George","year":"2000","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b45","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1182\/blood.V80.8.1890.bloodjournal8081890","article-title":"Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic.","volume":"80","author":"Thompson","year":"1992","journal-title":"Blood"},{"key":"2021012917163511400_i1543-2165-126-11-1430-b46","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.5858\/2002-126-1277-COAPCC","article-title":"College of American Pathologists Consensus Conference XXXVI: Diagnostic Issues in Thrombophilia: introduction and general considerations.","volume":"126","author":"Olson","year":"2002","journal-title":"Arch Pathol Lab Med"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/11\/1430\/2728101\/0003-9985(2002)126_1430_ttpath_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/11\/1430\/2728101\/0003-9985(2002)126_1430_ttpath_2_0_co_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:50Z","timestamp":1764790610000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/11\/article-p1430.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2002-126-1430-ttpath","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}